Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer
Clinical trial NCT05578053 · RECRUITING
Trial details
- NCT number
- NCT05578053
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-13
- Primary completion
- 2028-12-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.